UAM_Biblioteca | Unified search engine | Scientific Production Portal | UAM Research Data Repository
Universidad Autónoma de Madrid
Biblos-e Archivo
We are onFacebookCanal BiblosYouTubeTwitterPinterestWhatsappInstagram
    • español
    • English
  • English 
    • español
    • English
  • Log in
JavaScript is disabled for your browser. Some features of this site may not work without it.

Search Biblos-e Archivo

Advanced Search

Browse

All of Biblos-e ArchivoCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsFacultiesThis CollectionBy Issue DateAuthorsTitlesSubjectsFaculties

My Account

Log inRegister

Statistics

View Usage Statistics

Help

Information about Biblos-e ArchivoI want to submit my workI want to submit my doctoral thesisFrequently Asked QuestionsCopyrightsFinancial Agencies and OA policy

UAM_Biblioteca

View Item 
  •   Biblos-e Archivo
  • 1 - Producción científica en acceso abierto de la UAM
  • Producción científica en acceso abierto de la UAM
  • View Item
  •   Biblos-e Archivo
  • 1 - Producción científica en acceso abierto de la UAM
  • Producción científica en acceso abierto de la UAM
  • View Item

Safety and efficacy clinical trials for SYL1001, a novel short interfering RNA for the treatment of dry eye disease

Author
Benitez-Del-Castillo, José Manuel; Moreno-Montañés, Javier; Jiménez-Alfaro, Ignacio; Muñoz-Negrete, Francisco José; Turman, Krista; Palumaa, Kadi; Sádaba, Belén; González, María Victoria; Ruz, Verónica; Vargas, Beatriz; Pañeda, Covadonga; Martínez, Tamara; Bleau, Anne Marie; Jimenez, Ana Isabel
Entity
UAM. Departamento de Cirugía; Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD)
Publisher
Association for Research in Vision and Ophthalmology
Date
2016-11-01
Citation
10.1167/ iovs.16-20303
Investigative Ophthalmology & Visual Science 57.14 (2016): 6447-6454
 
 
 
ISSN
0146-0404
DOI
10.1167/ iovs.16-20303
Funded by
Supported by a grant from the 2012 INNPACTO program of the Spanish Ministry of Science and Innovation: INDREYE (Innovative solutions for the treatment and diagnosis of dry eye disease) grant number IPT-2012-0438-010000 (Madrid, Spain).
Project
Gobierno de España. IPT-2012-0438-010000; Gobierno de España. INNPACTO 2012
Editor's Version
https://doi.org/10.1167/ iovs.16-20303
Subjects
Dry eye disease; Ocular pain; siRNA; Visual analogue scale; Medicina
URI
http://hdl.handle.net/10486/679087
Rights
© 2016, Association for Research in Vision and Ophthalmology Inc.

Licencia Creative Commons
Esta obra está bajo una Licencia Creative Commons Atribución 4.0 Internacional.

Abstract

PURPOSE. To evaluate the efficacy and safety of SYL1001, a short interfering (si) RNA targeting the transient receptor potential cation channel subfamily V member 1 (TRPV1), for the treatment of dry eye disease (DED). METHODS. This study combines a phase I and two phase II clinical trials to test different doses of SYL1001 in a total of 156 healthy subjects and patients with DED. After 10 days of treatment, the primary efficacy endpoints were the effect on (1) the scoring in the Visual Analogue Scale (VAS) and Ocular Surface Disease Index (OSDI) questionnaires, and (2) ocular tolerance evaluated by corneal fluorescein staining and conjunctival hyperemia. Secondary endpoints included the assessment of systemic and local tolerance. RESULTS. Topical administration of SYL1001 1.125% once daily produced a significant decrease in VAS scores compared with placebo from day 4 until the end of treatment (change from baseline at day 10: -1.73 ± 0.32 vs. -0.91 ± 0.34; P = 0.013). For all treatments, OSDI scores were significantly reduced compared to their respective baseline values (P < 0.01), although no significant changes were detected between groups. Conjunctival hyperemia (quantified as normal or abnormal) significantly improved after instillation of SYL1001 1.125% compared with placebo (50% vs. 20%; P < 0.05). Excellent tolerability was reported, with no differences in the rates of occurrence of adverse events between groups. CONCLUSION. These trials achieved their primary endpoints of identifying the most effective dose of SYL1001 (1.125%). SYL1001 showed a large safety margin and may provide novel therapeutic opportunity for the relief of dry eye. (ClinicalTrials.gov numbers, NCT01438281, NCT01776658, and NCT02455999.) Eliminar seleccionado
Show full item record

Files in this item

Thumbnail
Name
safety_benitez_iovs_2016.pdf
Size
491.9Kb
Format
PDF

Refworks Export

Delicious Save this on Delicious

Google™ Scholar:Benitez-Del-Castillo, José Manuel - Moreno-Montañés, Javier - Jiménez-Alfaro, Ignacio - Muñoz-Negrete, Francisco José - Turman, Krista - Palumaa, Kadi - Sádaba, Belén - González, María Victoria - Ruz, Verónica - Vargas, Beatriz - Pañeda, Covadonga - Martínez, Tamara - Bleau, Anne Marie - Jimenez, Ana Isabel

This item appears in the following Collection(s)

  • Producción científica en acceso abierto de la UAM [15083]

Related items

Showing items related by title, author, creator and subject.

  • Efficacy and safety study of allogeneic equine umbilical cord derived mesenchymal stem cells ( EUC-MSCs) for the treatment of clinical symptomatology associated with mild to moderate degenerative joint disease (osteoarthritis) in horses under field conditions 

    Pradera Muñoz, Almudena
    2019-11-22
  • Efficacy of prospective pharmacogenetic testing in the treatment of major depressive disorder: Results of a randomized, double-blind clinical trial 

    Pérez, Víctor; Salavert, Ariana; Espadaler, Jordi; Tuson, Miquel; Saiz-Ruiz, Jerónimo; Sáez-Navarro, Cristina; Bobes, Julio; Baca-García, Enrique; Vieta, Eduard; Olivares, José M.; Rodriguez-Jiménez, Roberto; Villagrán, José M.; Gascón, Josep; Cañete-Crespillo, Josep; Solé, Montse; Saiz, Pilar A.; Ibáñez, Ángela; Diego-Adeliño, Javier de; AB-GEN Collaborative Group; Menchón, José M.
    2017-07-14
  • Differential body composition effects of protease inhibitors recommended for initial treatment of HIV infection: A randomized clinical trial 

    Martinez, Esteban; Gonzalez-Cordon, Ana; Ferrer, Elena; Domingo, Pere; Negredo, Eugenia; Gutierrez, Felix; Portilla, Joaquin; Curran, Adrià; Podzamczer, Daniel; Ribera, Esteban; Murillas, Javier; Bernardino, Jose I.; Santos, Ignacio; Carton, Jose A.; Peraire, Joaquim; Pich, Judit; Deulofeu, Ramon; Pérez, Ignacio; Gatell, Jose M.; Arnaiz, Juan A.; Beleta, Helena; Garcia, David; Pejenaute, Andrea; Ramos, Nuria; Arcaina, P.; Giner, L.; Moya, S.; Pampliega, M.; Portilla, J.; Barrera, G.; Podzamczer, Daniel; Rozas, N.; Saumoy, M.; Ferrer, E.; Asensi, V.; Cartón, J. A.; Gatell, J. M.; González-Cordón, A.; Pérez, I.; Martínez, E.; Masiá, M.; Padilla, S.; Ramos, J. R.; Robledano, C.; Gutiérrez, F.; Puig, J.; Negredo, E.; Arribas López, José RamónAutoridad UAM; Castro, J. M.; Bernardino, J. I.; Sanz, J.; Santos, I.; Cairó, M.; Velli, P.; Dalmau, D.; Lamas, A.; Martí-Belda, P.; Dronda, F.; Blanco, J. R.; Gutierrez, M.; Mateo, M. G.; Domingo, P.; Losada, E.; Prieto, A.; Antela, A.; Murillas, J.; Aguilar, A.; Peraire, J.; Vargas, M.; Viladés, C.; Vidal, F.; Crespo, M.; Curran, A.; Ribera, Esteban; Arnaiz, J. A.; Beleta, H.; Garcia, D.; Pejenaute, Andrea; Ramos, Nuria; Pich, J.
    2015-01-01
All the documents from Biblos-e Archivo are protected by copyrights. Some rights reserved.
Universidad Autónoma de Madrid. Biblioteca
Contact Us | Send Feedback
We are onFacebookCanal BiblosYouTubeTwitterPinterestWhatsappInstagram
 

 

All the documents from Biblos-e Archivo are protected by copyrights. Some rights reserved.
Universidad Autónoma de Madrid. Biblioteca
Contact Us | Send Feedback
We are onFacebookCanal BiblosYouTubeTwitterPinterestWhatsappInstagram